Team finds 14 new biomarkers for type 2 diabetes

October 4, 2012
A research team led by Anna Floegel of the German Institute of Human Nutrition and Tobias Pischon of the Max Delbrueck Center for Molecular Medicine has identified 14 novel biomarkers for type 2 diabetes. Credit: Birgit Große/Copyright: DIfE

A research team led by Anna Floegel of the German Institute of Human Nutrition (DIfE) and Tobias Pischon of the Max Delbrueck Center for Molecular Medicine (MDC) has identified 14 novel biomarkers for type 2 diabetes. They can serve as basis for developing new methods of treatment and prevention of this metabolic disease. The biomarkers can also be used to determine diabetes risk at a very early point in time. At the same time the markers enable insight into the complex mechanisms of this disease, which still have not been completely elucidated.

The researchers studied the blood of from three different studies with respect to their metabolites (metabolomics). The study was based on data and blood samples of the prospective EPIC-Potsdam study with more than 27,500 study participants, the Tuebingen family study and the KORA study. The study was conducted in collaboration with the German Center for Diabetes Research (DZD) and funded by the Federal Ministry of Education and Research (BMBF).

Metabolomics is still a young research field and serves the understanding of biological systems. It studies the dynamic network of metabolites of an organism and thus provides insight into ongoing . Metabolites have quite diverse functions. For instance, they play a role in and regulation, transport energy or are building material for the cells. Changes in metabolite concentrations may therefore directly reflect alterations in metabolism and thereby, shed light on the pathogenesis or presence of disease.

The aim of the current study was to identify metabolites in blood which provide insight into the pathomechanisms of type 2 diabetes and in addition can be used as biomarkers to determine the disease risk. To this end, the researchers studied a total of 4,000 blood samples. About 3,000 of these samples came from the EPIC-Potsdam study, nearly 900 samples from the KORA study in Augsburg and 76 from the study in Tuebingen. At the time the blood sample was taken, none of the study participants suffered from type 2 diabetes: However, during the average follow-up time of seven years, 800 Potsdam study participants and 91 Augsburg participants were diagnosed with type 2 diabetes. The 76 participants in the Tuebingen study were already classified at the beginning of the study as individuals at high risk for type 2 diabetes. At the time the blood sample was taken, however, they were still healthy.

163 metabolites analyzed per blood sample Jerzy Adamski and his team at the Institute of Experimental Genetics of Helmholtz Zentrum Muenchen analyzed the concentrations of 163 metabolites per blood sample. Fourteen of these metabolites exhibited a strong association with the development of type 2 diabetes.

"In addition to simple sugars, the 14 identified metabolites include various protein components and choline-containing phospholipids which play a role in the structure of cell membranes and in the transport of blood lipids," said Anna Floegel, lead author of the study. "Our findings particularly indicate a previously unknown role of phospholipids in development. This is a first clue which should definitely be pursued."

"At the same time the metabolites can also be used as to precisely determine the risk of diabetes at a very early stage, since the study is based on prospective data, that is data that were collected before the onset of the disease," said Tobias Pischon, who led the study. "The results of the new metabolomic analysis thus provide a good basis for developing new treatment and prevention methods."

Explore further: Genetic regulation of metabolomic biomarkers -- paths to cardiovascular diseases and type 2 diabetes

More information: Identification of Serum Metabolites Associated with Risk of Type 2 Diabetes Using a Targeted Metabolomic Approach, Diabetes, A. Floegel et al., 2012; DOI 10.2337/db12-0495

Related Stories

Genetic regulation of metabolomic biomarkers -- paths to cardiovascular diseases and type 2 diabetes

January 29, 2012
In a study to the genetic variance of human metabolism, researchers have identified thirty one regions of the genome that were associated with levels of circulating metabolites, i.e., small molecules that take part in various ...

Metabolomics as a basis for gender-specific drugs

August 11, 2011
Analyses of the metabolic profile of blood serum have revealed significant differences in metabolites between men and women. In a study to be published on August 11 in the open-access journal PLoS Genetics, scientists at ...

Genetics meets metabolomics

September 1, 2011
Scientists at Helmholtz Zentrum Munich and LMU Munich, in cooperation with Wellcome Trust Sanger Institute and King's College London (KCL), have identified several associations between genetic variants and specific metabolic ...

Recommended for you

Skimping on sleep may contribute to gestational diabetes

October 17, 2017
The amount of time spent sleeping in the United States has dropped significantly in the past twenty years with almost a quarter of women and 16 percent of men experiencing insufficient sleep. Now, a new study has found that ...

Artificial pancreas performs well in clinical trial

October 16, 2017
During more than 60,000 hours of combined use of a novel artificial pancreas system, participants in a 12-week, multi-site clinical trial showed significant improvements in two key measures of well-being in people living ...

Omega-6 fats may help prevent type 2 diabetes

October 11, 2017
The risk of developing type 2 diabetes could be significantly reduced by eating a diet rich in omega-6 polyunsaturated fats, a new study suggests.

Where there's type 1 diabetes, celiac disease may follow

October 10, 2017
(HealthDay)—Parents of young children with type 1 diabetes need to be on the lookout for symptoms of another autoimmune condition—celiac disease, new research suggests.

Type 1 diabetes and the microbiota—MAIT cells as biomarkers and new therapeutic targets

October 10, 2017
Together with colleagues from AP-HP Necker–Enfants Malades Hospital in Paris, scientists from the Cochin Institute (CNRS / INSERM / Paris Descartes University) have discovered that the onset of type 1 diabetes is preceded ...

Likely new treatment target identified for diabetic retinopathy

October 10, 2017
In oxygen-compromising conditions like diabetes, the body grows new blood vessels to help, but the result is often leaky, dysfunctional vessels that make bad matters worse.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.